MARSICO CAPITAL MANAGEMENT LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 327 filers reported holding GW PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSICO CAPITAL MANAGEMENT LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2020$1,290,000
+25.4%
13,255
+58.1%
0.04%
+12.5%
Q2 2020$1,029,000
+32.6%
8,386
-5.3%
0.03%
-3.0%
Q1 2020$776,000
-56.3%
8,857
-47.9%
0.03%
-47.6%
Q4 2019$1,777,000
-75.3%
16,991
-72.8%
0.06%
-77.5%
Q3 2019$7,194,000
-31.6%
62,537
+2.5%
0.28%
-25.3%
Q2 2019$10,514,000
-15.7%
60,990
-17.5%
0.38%
-16.7%
Q1 2019$12,468,000
+72.5%
73,961
-0.3%
0.45%
+47.5%
Q4 2018$7,228,000
-54.6%
74,219
-19.5%
0.30%
-43.3%
Q3 2018$15,924,000
+983.3%
92,187
+473.2%
0.54%
+3486.7%
Q3 2015$1,470,00016,0830.02%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2019
NameSharesValueWeighting ↓
Lamond Capital Partners LLC 134,230$9,085,0005.95%
VHCP Management, LLC 311,853$21,106,0005.81%
Iguana Healthcare Management, LLC 60,000$4,061,0001.96%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 366,187$24,784,0000.95%
ACUTA CAPITAL PARTNERS, LLC 20,000$1,354,0000.92%
United Asset Strategies, Inc. 14,278$966,0000.41%
PRUDENTIAL PLC 823,408$55,728,0000.24%
Rock Springs Capital Management LP 28,000$1,895,0000.22%
CLOUGH CAPITAL PARTNERS L P 84,600$5,726,0000.20%
Eventide Asset Management 25,000$1,692,0000.18%
View complete list of GW PHARMACEUTICALS PLC shareholders